Bcl G Antibody (OTI6D1) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72204F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI6D1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Bcl G Antibody (OTI6D1) [FITC]
Immunogen
Recombinant protein fragment corresponding to amino acids 116-216 of human Bcl G (NP_620048) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Bcl G Antibody (OTI6D1) [FITC]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Bcl G
Alternate Names
apoptosis facilitator Bcl-2-like protein 14, Apoptosis regulator Bcl-G, Bcl2-L-14, BCL2-like 14 (apoptosis facilitator), BCL-G, BCLGbcl2-L-14
Gene Symbol
BCL2L14
Additional Bcl G Products
Product Documents for Bcl G Antibody (OTI6D1) [FITC]
Product Specific Notices for Bcl G Antibody (OTI6D1) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...